125 related articles for article (PubMed ID: 7547352)
1. Bacterial infection in cystic fibrosis (CF): special reference to mycobacteria and Burkholderia cepacia.
Hodson ME
Pediatr Pulmonol Suppl; 1995; 11():66-7. PubMed ID: 7547352
[No Abstract] [Full Text] [Related]
2. Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids.
Kazachkov M; Lager J; LiPuma J; Barker PM
Pediatr Pulmonol; 2001 Oct; 32(4):338-40. PubMed ID: 11568995
[TBL] [Abstract][Full Text] [Related]
3. Misidentification of a genomovar of Burkholderia cepacia by recA restriction fragment length polymorphism.
Moore JE; Millar BC; Xu J; Crowe M; Redmond AO; Elborn JS
J Clin Pathol; 2002 Apr; 55(4):309-11. PubMed ID: 11919219
[TBL] [Abstract][Full Text] [Related]
4. Survival after lung transplantation for cystic fibrosis in Sweden.
Gilljam M; Nyström U; Dellgren G; Skog I; Hansson L
Eur J Cardiothorac Surg; 2017 Mar; 51(3):571-576. PubMed ID: 28364441
[TBL] [Abstract][Full Text] [Related]
5. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages.
Agodi A; Barchitta M; Gianninò V; Collura A; Pensabene T; Garlaschi ML; Pasquarella C; Luzzaro F; Sinatra F; Mahenthiralingam E; Stefani S
J Hosp Infect; 2002 Mar; 50(3):188-95. PubMed ID: 11886194
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. The French Observatoire Burkholderia cepacia Study Group.
Segonds C; Chabanon G; Couetdic G; Michel-Briand Y; Bingen E
Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):841-2. PubMed ID: 8950569
[No Abstract] [Full Text] [Related]
7. [Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis].
Segonds C; Chabanon G
Ann Biol Clin (Paris); 2001; 59(3):259-69. PubMed ID: 11397673
[TBL] [Abstract][Full Text] [Related]
8. Suppurative mediastinitis secondary to Burkholderia cepacia in a patient with cystic fibrosis.
George RB; Cartier Y; Casson AG; Hernandez P
Can Respir J; 2006; 13(4):215-8. PubMed ID: 16779467
[TBL] [Abstract][Full Text] [Related]
9. Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients.
Ryley HC; Ojeniyi B; Høiby N; Weeks J
Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):755-8. PubMed ID: 8922580
[TBL] [Abstract][Full Text] [Related]
10. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?
LiPuma JJ
Transpl Infect Dis; 2001 Sep; 3(3):149-60. PubMed ID: 11493397
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
[TBL] [Abstract][Full Text] [Related]
12. Subdural empyema due to Burkholderia cepacia: an unusual complication after lung transplantation for cystic fibrosis.
Balfour-Lynn IM; Ryley HC; Whitehead BF
J R Soc Med; 1997; 90 Suppl 31(Suppl 31):59-64. PubMed ID: 9204013
[No Abstract] [Full Text] [Related]
13. Burkholderia cepacia infections in cystic fibrosis.
Burns JL; Saiman L
Pediatr Infect Dis J; 1999 Feb; 18(2):155-6. PubMed ID: 10048690
[No Abstract] [Full Text] [Related]
14. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center.
Vu-Thien H; Moissenet D; Valcin M; Dulot C; Tournier G; Garbarg-Chenon A
Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):876-9. PubMed ID: 8997562
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis.
Nunvar J; Kalferstova L; Bloodworth RA; Kolar M; Degrossi J; Lubovich S; Cardona ST; Drevinek P
PLoS One; 2016; 11(8):e0160975. PubMed ID: 27512997
[TBL] [Abstract][Full Text] [Related]
16. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S
Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887
[TBL] [Abstract][Full Text] [Related]
17. Burkholderia cepacia and cystic fibrosis--50 years on.
Moore JE; Elborn JS
Commun Dis Public Health; 2001 Jun; 4(2):114-6. PubMed ID: 11524998
[TBL] [Abstract][Full Text] [Related]
18. Burkholderia cepacia--a transmissible cystic fibrosis pathogen.
Burns JL
J Pediatr; 2001 Nov; 139(5):618-9. PubMed ID: 11713434
[No Abstract] [Full Text] [Related]
19. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis.
De Soyza A; McDowell A; Archer L; Dark JH; Elborn SJ; Mahenthiralingam E; Gould K; Corris PA
Lancet; 2001 Nov; 358(9295):1780-1. PubMed ID: 11734238
[TBL] [Abstract][Full Text] [Related]
20. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study.
Cazzola G; Amalfitano G; Tonolli E; Perazzoli C; Piacentini I; Mastella G
Acta Paediatr; 1996 May; 85(5):554-7. PubMed ID: 8827098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
